Market closed
Neuraxis Inc./$NRXS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
Ticker
$NRXS
Sector
Trading on
AMEX
Industry
Health Care Equipment & Supplies
Headquarters
Employees
21
Website
Neuraxis Inc. Metrics
BasicAdvanced
$12M
-
-$1.22
-
-
Price and volume
Market cap
$12M
52-week high
$2.70
52-week low
$1.48
Average daily volume
31K
Financial strength
Current ratio
1.753
Quick ratio
1.62
Long term debt to equity
12.405
Total debt to equity
22.895
Interest coverage (TTM)
-23.80%
Management effectiveness
Return on assets (TTM)
-169.85%
Return on equity (TTM)
-2,480.49%
Valuation
Price to revenue (TTM)
4.456
Price to book
5.86
Price to tangible book (TTM)
6.15
Price to free cash flow (TTM)
-1.954
Growth
Revenue change (TTM)
9.18%
Earnings per share change (TTM)
-72.83%
3-year revenue growth (CAGR)
-0.44%
3-year earnings per share growth (CAGR)
-13.98%
Neuraxis Inc. News
AllArticlesVideos
NeurAxis, Inc. (NRXS) Q4 2024 Earnings Call Transcript
Seeking Alpha·4 weeks ago
NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues
GlobeNewsWire·4 weeks ago
NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Neuraxis Inc. stock?
Neuraxis Inc. (NRXS) has a market cap of $12M as of April 16, 2025.
What is the P/E ratio for Neuraxis Inc. stock?
The price to earnings (P/E) ratio for Neuraxis Inc. (NRXS) stock is 0 as of April 16, 2025.
Does Neuraxis Inc. stock pay dividends?
No, Neuraxis Inc. (NRXS) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next Neuraxis Inc. dividend payment date?
Neuraxis Inc. (NRXS) stock does not pay dividends to its shareholders.
What is the beta indicator for Neuraxis Inc.?
Neuraxis Inc. (NRXS) does not currently have a Beta indicator.